- $78.52bn
- $89.05bn
- $7.05bn
- 73
- 26
- 59
- 53
Annual balance sheet for Synopsys, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,581 | 1,566 | 1,591 | 4,050 | 2,961 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 885 | 1,057 | 1,336 | 1,692 | 2,727 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,808 | 3,013 | 3,431 | 6,470 | 6,012 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 966 | 1,042 | 1,126 | 1,129 | 1,399 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,752 | 9,418 | 10,333 | 13,074 | 48,224 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,413 | 2,774 | 2,985 | 2,650 | 3,722 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3,457 | 3,902 | 4,186 | 4,083 | 19,897 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,295 | 5,516 | 6,147 | 8,991 | 28,328 |
| Total Liabilities & Shareholders' Equity | 8,752 | 9,418 | 10,333 | 13,074 | 48,224 |
| Total Common Shares Outstanding |